CWChristopher Wilson

Christopher Wilson

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Christopher Wilson has a total of 1000 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Comparing the evolvability of an ancestrally reconstructed and modern adenylate kinase

    by MacKenzie Patterson, Hannes Ludewig, Christopher Wilson, Daniel R. Woldring, Chansik Kim, Aedan Using, Joseph Irvin, Douglas L. Theobald, Dorothee Kern

    Directed evolution transformed protein engineering by providing a customizable framework for generating enzymes with improved catalytic performance across diverse functions. Yet modern enzymes often stall during directed evolution because populations become trapped on local fitness peaks. Researchers have suggested that ancestral enzymes offer better starting points because they are typically more thermostable. Here we propose and experimentally test an alternative explanation that does not depend on ancestral thermostability. We posit that ancestrally reconstructed sequences are unusually evolvable because they are inferred from the evolutionary lineages that survived to produce extant proteins. Less evolvable ancestors, and the trajectories emanating from them, disappeared by extinction and therefore do not contribute to reconstructed ancestors. Using thermophilic ancestral and modern adenylate kinases, we performed independent single-round selection experiments for activity in vivo and in vitro. In both settings, the ancestral enzyme tolerates a larger number of mutations, yielding more viable variants with greater genetic diversity than its modern descendants. Because mutational robustness promotes evolvability, these results support an intrinsic evolvability of reconstructed ancestral sequences that makes them superior launch points for directed evolution.

  • Top Cited Papers

    In vivo base editing rescues Hutchinson–Gilford progeria syndrome in mice

    by Luke W. Koblan, Michael R. Erdos, Christopher Wilson, Wayne A. Cabral, Jonathan M. Levy, Zheng-Mei Xiong, Urraca L. Tavarez, Lindsay M. Davison, Yantenew G. Gete, Xiaojing Mao, et al.

    Hutchinson–Gilford progeria syndrome (HGPS or progeria) is typically caused by a dominant-negative C•G-to-T•A mutation (c.1824 C>T; p.G608G) in LMNA, the gene that encodes nuclear lamin A. This mutation causes RNA mis-splicing that produces progerin, a toxic protein that induces rapid ageing and shortens the lifespan of children with progeria to approximately 14 years1,2,3,4. Adenine base editors (ABEs) convert targeted A•T base pairs to G•C base pairs with minimal by-products and without requiring double-strand DNA breaks or donor DNA templates5,6. Here we describe the use of an ABE to directly correct the pathogenic HGPS mutation in cultured fibroblasts derived from children with progeria and in a mouse model of HGPS. Lentiviral delivery of the ABE to fibroblasts from children with HGPS resulted in 87–91% correction of the pathogenic allele, mitigation of RNA mis-splicing, reduced levels of progerin and correction of nuclear abnormalities. Unbiased off-target DNA and RNA editing analysis did not detect off-target editing in treated patient-derived fibroblasts. In transgenic mice that are homozygous for the human LMNA c.1824 C>T allele, a single retro-orbital injection of adeno-associated virus 9 (AAV9) encoding the ABE resulted in substantial, durable correction of the pathogenic mutation (around 20–60% across various organs six months after injection), restoration of normal RNA splicing and reduction of progerin protein levels. In vivo base editing rescued the vascular pathology of the mice, preserving vascular smooth muscle cell counts and preventing adventitial fibrosis. A single injection of ABE-expressing AAV9 at postnatal day 14 improved vitality and greatly extended the median lifespan of the mice from 215 to 510 days. These findings demonstrate the potential of in vivo base editing as a possible treatment for HGPS and other genetic diseases by directly correcting their root cause.


  • Open Access

    Response to Comment on “Ancient origins of allosteric activation in a Ser-Thr kinase”

    by Christopher Wilson, Dorothee Kern

    Park et al . question one out of seven findings from Hadzipasic et al .: whether TPX2 allosterically regulates the oldest Aurora. We had already addressed the two concerns raised—sparse sequence sampling and not forcing the gene to the species tree—before publication. Moreover, we believe their ancestral sequence reconstruction would be consistent with a nonallosteric common ancestor, and we show large sequence differences caused by species tree–enforced gene trees.


  • Open Access

    Bimodal evolution of Src and Abl kinase substrate specificity revealed using mammalian cell extract as substrate pool

    by Patrick Finneran, Margaret Soucheray, Christopher Wilson, Renee Otten, Vanessa Buosi, Nevan J. Krogan, Danielle L. Swaney, Douglas L. Theobald, Dorothee Kern

    The specificity of phosphorylation by protein kinases is essential to the integrity of biological signal transduction. While peptide sequence specificity for individual kinases has been examined previously, here we explore the evolutionary progression that has led to the modern substrate specificity of two non-receptor tyrosine kinases, Abl and Src. To efficiently determine the substrate specificity of modern and reconstructed ancestral kinases, we developed a method using mammalian cell lysate as the substrate pool, thereby representing the naturally occurring substrate proteins. We find that the oldest tyrosine kinase ancestor was a promiscuous enzyme that evolved through a more specific last common ancestor into a specific human Abl. In contrast, the parallel pathway to human Src involved a loss of substrate specificity, leading to general promiscuity. These results add a new facet to our understanding of the evolution of signaling pathways, with both subfunctionalization and neofunctionalization along the evolutionary trajectories.


  • Top Cited Papers
    Open Access

    Programmable m6A modification of cellular RNAs with a Cas13-directed methyltransferase

    by Christopher Wilson, Peter J. Chen, Zhuang Miao, David R. Liu

    N6-Methyladenosine (m6A) is the most widespread internal messenger RNA modification in humans. Despite recent progress in understanding the biological roles of m6A, the inability to install m6A site specifically in individual transcripts has hampered efforts to elucidate causal relationships between the presence of a specific m6A and phenotypic outcomes. In the present study, we demonstrate that nucleus-localized dCas13 fusions with a truncated METTL3 methyltransferase domain and cytoplasm-localized fusions with a modified METTL3:METTL14 methyltransferase complex can direct site-specific m6A incorporation in distinct cellular compartments, with the former fusion protein having particularly low off-target activity. Independent cellular assays across multiple sites confirm that this targeted RNA methylation (TRM) system mediates efficient m6A installation in endogenous RNA transcripts with high specificity. Finally, we show that TRM can induce m6A-mediated changes to transcript abundance and alternative splicing. These findings establish TRM as a tool for targeted epitranscriptome engineering that can reveal the effect of individual m6A modifications and dissect their functional roles.


  • Top Cited Papers

    Determinants of Base Editing Outcomes from Target Library Analysis and Machine Learning

    by Mandana Arbab, Max W. Shen, Beverly Mok, Christopher Wilson, Żaneta Matuszek, Christopher A. Cassa, David R. Liu


  • Open Access

    Author Correction: Phage-assisted evolution of an adenine base editor with improved Cas domain compatibility and activity

    by Michelle F. Richter, Kevin T. Zhao, Elliot Eton, Audrone Lapinaite, Gregory A. Newby, Benjamin W. Thuronyi, Christopher Wilson, Luke W. Koblan, Jing Zeng, Daniel E. Bauer, et al.

    An amendment to this paper has been published and can be accessed via a link at the top of the paper.


  • Top Cited Papers

    Phage-assisted evolution of an adenine base editor with improved Cas domain compatibility and activity

    by Michelle F. Richter, Kevin T. Zhao, Elliot Eton, Audrone Lapinaite, Gregory A. Newby, Benjamin W. Thuronyi, Christopher Wilson, Luke W. Koblan, Jing Zeng, Daniel E. Bauer, et al.

    Applications of adenine base editors (ABEs) have been constrained by the limited compatibility of the deoxyadenosine deaminase component with Cas homologs other than SpCas9. We evolved the deaminase component of ABE7.10 using phage-assisted non-continuous and continuous evolution (PANCE and PACE), which resulted in ABE8e. ABE8e contains eight additional mutations that increase activity (kapp) 590-fold compared with that of ABE7.10. ABE8e offers substantially improved editing efficiencies when paired with a variety of Cas9 or Cas12 homologs. ABE8e is more processive than ABE7.10, which could benefit screening, disruption of regulatory regions and multiplex base editing applications. A modest increase in Cas9-dependent and -independent DNA off-target editing, and in transcriptome-wide RNA off-target editing can be ameliorated by the introduction of an additional mutation in the TadA-8e domain. Finally, we show that ABE8e can efficiently install natural mutations that upregulate fetal hemoglobin expression in the BCL11A enhancer or in the the HBG promoter in human cells, targets that were poorly edited with ABE7.10. ABE8e augments the effectiveness and applicability of adenine base editing.


  • Open Access

    Ancient origins of allosteric activation in a Ser-Thr kinase

    by Adelajda Hadzipasic, Christopher Wilson, Vy Nguyen, Nadja Kern, Chansik Kim, Warintra Pitsawong, Janice Villali, Yuejiao Zheng, Dorothee Kern

    Evolution of a kinase allosteric site: Enzyme activity is often regulated by conformational changes coupled to binding of an effector at an allosteric site, a feature especially important for enzymes involved in signaling cascades. Hadzipasic et al. studied the origins of allosteric regulation of Aurora A, a kinase involved in progression of the eukaryotic cell cycle. Aurora A is allosterically regulated through the binding of an effector protein named TPX2, which also targets the kinase to spindle microtubules. By reconstructing ancestor kinase sequences, they found that TPX2 bound to an early Aurora A but had very weak activation that was gradually strengthened by evolution of an allosteric network within the kinase. An evolutionary advantage from localizing the active protein at the mitotic spindle may have driven the development of this regulatory mechanism. Science , this issue p. 912


  • Top Cited Papers

    Search-and-replace genome editing without double-strand breaks or donor DNA

    by Andrew V. Anzalone, Peyton B. Randolph, Jessie R. Davis, Alexander A. Sousa, Luke W. Koblan, Jonathan M. Levy, Peter J. Chen, Christopher Wilson, Gregory A. Newby, Aditya Raguram, et al.

    Most genetic variants that contribute to disease1 are challenging to correct efficiently and without excess byproducts2–5. Here we describe prime editing, a versatile and precise genome editing method that directly writes new genetic information into a specified DNA site using a catalytically impaired Cas9 fused to an engineered reverse transcriptase, programmed with a prime editing guide RNA (pegRNA) that both specifies the target site and encodes the desired edit. We performed more than 175 edits in human cells including targeted insertions, deletions, and all 12 types of point mutation without requiring double-strand breaks or donor DNA templates. We applied prime editing in human cells to correct efficiently and with few byproducts the primary genetic causes of sickle cell disease (requiring a transversion in HBB) and Tay-Sachs disease (requiring a deletion in HEXA), to install a protective transversion in PRNP, and to insert various tags and epitopes precisely into target loci. Four human cell lines and primary post-mitotic mouse cortical neurons support prime editing with varying efficiencies. Prime editing offers efficiency and product purity advantages over homology-directed repair, complementary strengths and weaknesses compared to base editing, and much lower off-target editing than Cas9 nuclease at known Cas9 off-target sites. Prime editing substantially expands the scope and capabilities of genome editing, and in principle could correct about 89% of known pathogenic human genetic variants.